Company: ACHV
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0000950170-25-036831
Chunk: 140

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 8
Chunk 140
---
5

We have served as the Company's auditor since 2017. 

67

Achieve Life Sciences, Inc. 

Consolidated Balance Sheets 

(In thousands, except per share and share amounts) 

    December 31,

    2024

    2023

    ASSETS

    Current assets:

    Cash and cash equivalents [note 3 and note 7]
     
    $
    12,753

    $
    15,546

    Marketable securities [note 7]

    21,607

    —

    Grant receivable [note 4]

    —

    111

    Prepaid expenses and other assets

    2,107

    1,325

    Total current assets

    36,467

    16,982

    Restricted cash and other assets [note 7 and note 8]

    39

    92

    Right-of-use assets [note 12]

    119

    66

    License agreement [note 5 and note 6]

    974

    1,197

    Goodwill

    1,034

    1,034

    Total assets
     
    $
    38,633

    $
    19,371

    LIABILITIES AND STOCKHOLDERS' EQUITY

    Current liabilities:

    Accounts payable
     
    $
    1,950

    $
    618

    Accrued liabilities other

    573

    351

    Accrued clinical liabilities

    1,077

    280

    Accrued compensation

    3,027

    2,311

    Contingent consideration [note 6 and note 7]

    —

    528

    Current portion of long-term obligations [note 12]

    55

    63

    Current portion of convertible debt [note 7 and note 9]

    —

    16,662

    Total current liabilities

    6,682

    20,813

    Non-current liabilities:

    Non-current portion of convertible debt [note 7 and note 9]

    9,837

    —

    Contingent consideration [note 6 and note 7]

    1,149

    —

    Long-term obligations [note 12]

    66

    6

    Total liabilities